Gabapentin Tablet
Product Images NDC 72162-1530

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 72162-1530). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

A line graph showing mean pain scores over eight weeks comparing placebo and Gabapentin at 3600 mg/day. The x-axis represents weeks with a baseline, followed by an initial 4-week dose titration period and a 4-week fixed dose period. The y-axis indicates mean pain scores from 0 to 10. Gabapentin shows a decline in mean pain score over time, while placebo remains relatively stable.*

FDA Label Image

Figure 2 (Image 02)

A line graph depicting mean pain score over a 7-week period for placebo and two gabapentin dosage groups (1800 mg/day and 2400 mg/day). The x-axis represents weeks starting from baseline, and the y-axis shows mean pain scores ranging from 0 to 10. The study timeline includes a 3-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies,' showing results from two studies. The vertical axis represents percentage responders from 0% to 100%. Study 1 compares placebo (12%) and Gabapentin 3600 mg (29%). Study 2 compares placebo (14%), Gabapentin 1800 mg (32%), and Gabapentin 2400 mg (34%). Statistical significance is noted with p-values < 0.01 and < 0.001.*

FDA Label Image

Image-04 (Image 04)

A mathematical formula illustrating the calculation of creatinine clearance (ClCr) using age, weight, and serum creatinine levels, with a factor adjustment for female patients (multiplication by 0.85).*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of Gabapentin showing a cyclohexane ring attached to amino and carboxyl functional groups. The image depicts the molecular arrangement consistent with Gabapentin's known chemical formula.*

FDA Label Image

Image-09 (Image 09)

A scatter plot showing the percentage difference on the vertical axis and daily dose in milligrams on the horizontal axis for Gabapentin. The graph compares three studies labeled a, b, and c, with dose points at 600, 900, 1200, and 1800 mg. Each study is represented by differently shaded square markers.*

FDA Label Image

Label (Lbl721621530)

Label for Gabapentin Tablets, USP 600 mg, oral tablet form, in a package of 100 tablets. The label displays the NDC 72162-1530-1 and indicates it is a prescription drug by Bryant Ranch Prepack, relabeled by Bryant Ranch Prepack, Inc., and manufactured by ScieGen Pharmaceuticals, Inc. Storage and safety instructions are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.